Viewing Study NCT02197767

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-01-05 @ 11:55 PM
Study NCT ID: NCT02197767
Status: COMPLETED
Last Update Posted: 2019-02-06
First Post: 2014-07-21
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fibrillary Glomerulonephritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None fibrillary glomerulonephritis View
None rituximab View
None Rituxan View
None MabThera View
None Zytux™ View